AI-generated summary
The authors conducted a scoping review of published studies on photobiomodulation for eye and vision conditions in children and young people aged 0 to 18. They included 45 studies, mostly on myopia control, and report reduced axial elongation along with some rebound effects after stopping treatment. They describe PBMT as having potential benefits and a generally favourable safety profile, but state that further research is needed.
- Studies included
- 45
- Who or what was studied
- Children and young people aged 0 to 18 years with eye, vision, eyelid or orbital conditions
- Wavelengths
- 400, 1100 nm
- Limits stated in the abstract
- The authors state that further research is needed to optimise protocols and assess sustained efficacy and safety.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 400-1100 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Myopia, Photodynamic therapy, Systematic review, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.